http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020262848-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_383ba12b927af7302462313c4accd521 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
filingDate | 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f586d01560df215b262c8d340bd9c5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03bcf28d362df09780f87e30b5059472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3a706f651d45877f7763ac6f45f030 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b36ea447ca48ef5f56b51aafeda3dbc |
publicationDate | 2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2020262848-A1 |
titleOfInvention | Novel process for the preparation tavaborole and its intermediates |
abstract | The present invention provides a novel and improved process for the preparation of Tavaborole of Formula (I) and its pharmaceutically acceptable salts. The present invention also provides novel intermediates and process for the preparation of intermediates used in the preparation of Tavaborole. The present invention also provides an improved process for the preparation of Tavaborole and pharmaceutically acceptable salts thereof, that is commercially and industrially scalable. |
priorityDate | 2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 128.